MEM-288

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMEM-288
Drug Alias NameMEM-288
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsInterferon beta stimulantsCD40 ligand stimulants
TargetsCD40 ligandInterferon beta
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemgen
China Registration ClassN/A

Develop Information

Active CompaniesMemgen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung +[9] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A